Mesenchymal Stem Cells

Handbook of Stem Cells

Volumn 2, Issue , 2004, Pages 299-308

  Caplan, Arnold I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34147114745     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012436643-5/50118-8     Document Type: Chapter

References (124)

1. Caplan A.I., Zwilling E., Kaplan N.O. 3- Acetylpyridine: effects in vitro related to teratogenic activity in chick embryos. Science 1968, 160:1009-1010.
2. Caplan A.I. Effects of the nicotinamide-sensitive teratogen 3- acetylpyridine on chick limb cells in culture. Exp. Cell Res. 1970, 62:341-355.
3. Caplan A.I. Effects of a nicotinamide-sensitive teratogen 6- aminonicotinamide on chick limb cells in culture. Exp. Cell Res. 1972, 70:185-195.
4. Caplan A.I. The effects of the nicotinamide-sensitive teratogen 3- acetylpyridine on chick limb mesodermal cells in culture: biochemical parameters. J. Exp. Zool. 1972, 180:351-362.
5. Caplan A.I., Koutroupas S. The control of muscle and cartilage development in the chicklimb: the role of differential vascularization. J. Embryol. Exp. Morph. 1973, 29:571-583.
6. Caplan A.I., Stoolmiller A.C. Control of chondrogenic expression in mesodermal cells of embryonic chick limb. Proc. Natl. Acad. Sci. U. S. A. 1973, 70:1712-1717.
7. Caplan A.I. The molecular control of muscle and cartilage development. 39th Annual Symposium of the Society for Developmental Biology 1981, 37-68. Alan R. Liss, St. Louis. S. Subtelney (Ed.).
8. Caplan A.I. Cartilage. Sci. Am. 1984, 251:84-94.
9. Hascall V.C., Oegema T.R., Brown M., Caplan A.I. Isolation and characterization of proteoglycans from avianembryonic limb bud chondrocytes grown in vitro. J. Biol. Chem. 1976, 251:3511-3519.
10. Deluca S., Heinegard D., Hascall V.C., Kimura J.H., Caplan A.I. Chemical and physical changes in proteoglycans during development of chick limb bud chondrocytes grown in vitro. J. Biol. Chem. 1977, 252:6600-6608.
11. Deluca S., Caplan A.I., Hascall V.C. Biosynthesis of proteoglycans by chick limb bud chondrocytes. J. Biol. Chem. 1978, 253:4713-4720.
12. Caplan A.I., Hascall V.C. Structure and development changes in proteoglycans. Dilatation of the Uterine Cervix 1980, 79-98. Raven Press, New York. F. Naftolin (Ed.).
13. Caplan A.I., Fiszman M.Y., Eppenberger H.M. Molecular and cell isoforms during development. Science 1983, 221:921-927.
14. Melching L.I., Cs-Szabo G., Roughley P.J. Analysis of proteoglycan messages in human articular cartilage by a competitive PCR technique. Matrix Biol. 1997, 16:1-11.
15. Urist M.R. Bone: Formation by autoinduction. Science 1965, 150:839-899.
16. Urist M.R., Lietze A., Mizutani H., Takagi K., Tiffitt J.T., Amstutz J., Delange R., Termine J., Finerman G.A.M. A bovine low-molecular-weight bone morphogenetic protein (BMP) fraction. Clin. Orthop. 1982, 162:219-232.
17. Van de Putte K.A., Urist M.R. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix. Clin. Ortho. Rel. Res. 1996, 43:257-270.
18. Urist M.R., Kovacs S., Yates K.A. Regeneration of an enchondroma defect under the influence of an implant of human bone morphogenetic protein. J. Hand Surg. 1986, 11(A):417-419.
19. Urist M.R. The search for and discovery of bone morphogenetic protein (BMP). Bone Grafts Derivatives and Substitutes 1994, 315-362. Butterworth Heinemann, New York. M.R. Urist (Ed.).
20. Syftestad G.T., Caplan A.I. A fraction from extracts from demineralized bone stimulates the conversion of mesenchymal cells into chondrocytes. Dev. Biol. 1984, 104:348-356.
21. Syftestad G.T., Caplan A.I. Effects of osteoinductive bone matrix extracts on the transition of mesenchymal cells into chondrocytes. Calc. Tiss. Intl. 1984, 36:625-627.
22. Syftestad G.T., Lucas P.A., Caplan A.I. The in vitro chondrogenic response of limb bud mesenchyme to a watersoluble fraction prepared from demineralized bone matrix. Differentiation 1985, 29:230-237.
23. Caplan A.I., Syftestad G.T. Bone protein purification process 1986, Patent No. 4,608,199.
24. Caplan A.I., Syftestad G.T. Process of adapting soluble bone protein for use in stimulating osteoinduction 1986, Patent No. 4,620,327.
25. Wozney J.M., Rosen V., Celest A.J., Mitsock L.M., Whitters J.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
26. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol. Repro. Dev. 1992, 32:160-167.
27. Caplan A.I. Mesenchymal stem cells. J. Ortho. Res. 1991, 9:641-650.
28. Marshall C.J., Adrian J.T. The embryonic origins of human hematopoiesis. Br. J. Heamatol. 2001, 112:838-850.
29. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
30. Owen M. Marrow stromal stem cells. J. Cell. Sci. Suppl. 1988, 10:63-76.
31. Friedenstein A.J. Precursor cells of mechanocytes. Int. Rev. Cytol. 1976, 47:327-355.
32. Friedenstein A.J., Chailakhyan R.K., Gerasimov U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tiss. Kinet. 1987, 20:263-272.
33. Caplan A.I. The mesengenic process. Clin. Plas. Surg. 1994, 21:429-435.
34. Pechak D.G., Kujawa M.J., Caplan A.I. Morphological and histological events during first bone formation in embryonic chick limbs. Bone 1986, 7:441-458.
35. Pechak D.G., Kujawa M.J., Caplan A.I. Morphology of bone development and bone remodeling in embryonic chick limbs. Bone 1986, 7:459-472.
36. Caplan A.I., Pechak D.G. The cellular and molecular embryology of bone formation. Bone and Mineral Research 1987, 117-184. Elsevier, London. W.A. Peck (Ed.).
37. Caplan A.I. Bone development. CIBA Foundation Symposium 136 1988, 3-21. Wiley, New York.
38. Osdoby P., Caplan A.I. Osteogenesis in cultures of limb mesenchymal cells. Dev. Biol. 1979, 73:84-102.
39. Osdoby P., Caplan A.I. Scanning electron microscopy of in vitro osteogenesis. Calcif. Tiss. Intl. 1980, 30:43-50.
40. Osdoby P., Caplan A.I. First bone formation in embryonic chick limbs. Dev. Biol. 1981, 86:147-156.
41. Osdoby P., Caplan A.I. Characterization of a bonespecific alkaline phosphatase in cultures of chick limb mesenchymal cells. Dev. Biol. 1981, 86:136-146.
42. Syftestad G.T., Weitzhandler M., Caplan A.I. Isolation and characterization of osteogenic cells derived from first bone of the embryonic tibia. Dev. Biol. 1985, 110:275-283.
43. Bruder S.P., Caplan A.I. First bone formation and the dissection of an osteogenic lineage in the embryonic chick tibia is revealed by monoclonal antibodies against osteoblasts. Bone 1989, 10:359-375.
44. Bruder S.P., Caplan A.I. Cellular and molecular events during embryonic bone development. Conn. Tiss. Res. 1989, 20:65-71.
45. Bruder S.P., Caplan A.I. Discrete stages within the osteogenic lineage are revealed by alterations in the cell surface architecture of embryonic bone cells. The Chemistry and Biology of Mineralized Tissue 1989, 73-79. Gordon and Breach, Chichester. M.J. Glimcher (Ed.).
46. Bruder S.P., Caplan A.I. Cellular and molecular events during embryonic bone development. The Chemistry and Biology of Mineralized Tissue 1989, 65-71. Gordon and Breach, New York. M.J. Glimcher (Ed.).
47. Stockdate F.E., Miller J.B., Fedman J.L., Lamson G., Hager J. Myogenic cell lineages: Commitment and modulation during differentiation of avian muscle. Cell. Mol. Biol. Muscle Dev. 1989, 3-13. Alan R. Liss, Inc., New York.
48. Stockdale F.E. Mechanisms of formation of muscle fiber types. Cell Struct. Funct. 1997, 22:37-43.
49. Dexter T.M. Stromal cell-associated hemopoiesis. J. Cell. Physiol. Suppl. 1982, 1:87-94.
50. Dexter T.M., Allen T.D., Lajtha L.G. Conditions controlling the proliferation of hemopoietic stems cells in vitro. J. Cell. Physiol. 1977, 91:335-344.
51. Lazarus H.M., Thiede M.A., Haynesworth S.E., Gerson S.L., Caplan A.I. Human bone marrow-derived mesenchymal progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J. Hematother. 1998, 6:447-455.
52. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
53. Deasy B.M., Qu-Peterson Z., Greenberger J.S., Huard J. Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 2002, 20:50-60.
54. Gimble J.M., Robinson C.E., Wu X., Kelly K.A. The function of adipocytes in the bone marrow stroma: an update. Bone 1996, 19:421-428.
55. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tiss. Eng. 2001, 7:211-228.
56. Mizuno S., Glowacki J. Chondroinduction of human dermal fibroblasts by demineralized bone in three-dimensional culture. Exp. Cell Res. 1996, 227:89-97.
57. Tallheden T., Dennis J.E., Lennon D.P., Sjögren-Jansson E., Caplan A.I., Lindahl A. Phenotypic plasticity of human articular chondrocytes. J. Bone Joint Surg. 2003, 85-A(Suppl 2):93-100.
58. Nutall M.E., Patton A.J., Olivera D.L., Nadeau D.P., Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotypes: implications for osteogenic disorders. J. Bone Miner. Res. 1998, 13:371-382.
59. Schor A.M., Canfield A.E. Osteogenic potential of vascular pericytes. Marrow Stromal Cell Culture 1998, 128-148. Cambridge University Press, New York. J.N. Beresford (Ed.).
60. Wakitani S., Saito T., Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995, 18:1417-1426.
61. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture- expanded human mesenchymal stem cells in vitro. J. Cell Biochem. 1997, 64:295-312.
62. Dennis J.E., Caplan A.I. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of anH-2Kb-tsA58 transgenic mouse. J. Cell. Physiol. 1996, 167:523-538.
63. Dennis J.E., Merriam A., Awadallah A., Yoo J.U., Johnstone B., Caplan A.I. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner Res. 1999, 14:700-709.
64. Haynesworth S.E., Baber M.A., Caplan A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992, 13:69-80.
65. Dennis J.E., Carbillet J.P., Caplan A.I., Charbord P. The STRO-1+ marrow cell population is multipotential. Cells Tis. Organs 2002, 170:73-82.
66. Dennis J.E., Charbord P. Origin and differentiation of human and murine stroma. Stem Cells 2002, 20:205-214.
67. Dennis J.E. Mesenchymal progenitor cells in adult marrow. Biology 1995, 203. Case Western Reserve University, Cambridge.
68. Jat P.S., Nobel M.D., Ataloitis P., Tanaka Y., Yannoutsos N., Larsen L., Kioussis K. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:5096-5100.
69. Haynesworth S.E., Goldberg V.M., Caplan A.I. Diminution of the number of mesenchymal stem cells as a cause for skeletal aging. Musculoskeletal Soft-Tissue Aging: Impact on Mobility 1994, 79-87. American Academy of Orthopaedic Surgeons, Cleveland. J.A. Buckwalter (Ed.).
70. Muschler G.F., Midura R.J. Connective tissue progenitors: practical concepts for clinical applications. Clin. Ortho. Rel. Res. 2002, 395:66-80.
71. Lennon D.P., Haynesworth S.E., Bruder S.P., Jaiswall N., Caplan A.I. Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. In Vitro Cell Develop. Bio. 1996, 32:602-611.
72. Connolly J., Guise R., Lippiello L., Dehne R. Development of an osteogenic bone-marrow preparation. J. Bone Joint Surg. 1989, 71:684-691.
73. Connolly J.F. Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin. Ortho. Rel. Res. 1998, 355S:S257-S266.
74. Muschler G.F., Nitto H., Matsukura Y., Boehm C., Valdevit A., Kambic H., Davros W., Powell K., Easley K. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin. Ortho. Rel. Res. 2003, 407:102-118.
75. Bruder, S. Osteobiologics, DePuy. (Personal communication).
76. Caplan A.I., Goldberg V.M. The principles of tissue engineered regeneration of skeletal tissues. Clin. Orthop. Rel. Res. 1999, 367S:S12-S16.
77. Caplan A.I., Bruder S.P. Cell and molecular engineering of bone regeneration. Principles of Tissue Engineering 1996, 599-618. R.G. Landes, Rosemont, IL. R.P. Lanza (Ed.).
78. Caplan A.I. Tissue engineering strategies for mesenchymal or skeletal tissues. Tissue Engineering for Therapeutic Use 4: Proceedings of the Fourth International Symposium on Tissue Engineering 1999, 67-72. Elsevier Science/BV, Springer, NY. Y. Ikada (Ed.).
79. Pittenger M., Mackay A., Beck S., Jaiswal R., Douglas R., Mosca J., Moorman M., Simonetti D., Craig S., Marshak D. Multiple potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
80. Lennon D.P., Haynesworth S.E., Arm D.M., Baber M., Caplan A.I. Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteogenesis. Dev. Dyn. 2000, 219:50-62.
81. Caplan A.I., Haynesworth S.E. Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells 1993, Patent No. 5,197,985.
82. Caplan A.I., Haynesworth S.E. Method for treating connective tissue disorders 1993, Patent No. 5,226,914.
83. Caplan A.I., Haynesworth S.E. Human mesenchymal stem cells 1996, Patent No. 5,486,359.
84. Caplan A.I., Gerson S.L., Haynesworth S.E. Transduced mesenchymal stem cells 1997, Patent No. 5,591,625.
85. Young R.G., Butler D.L., Weber W., Gordon S.L., Fink D.J., Caplan A.I. The use of mesenchymal stem cells in Achilles tendon repair. J. Orthop. Res. 1998, 16:406-413.
86. Bruder S.P., Kurth A.A., Shea M., Hayes W.C., Jaiswal N., Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Ortho. Res. 1998, 16:155-162.
87. Jaiswal R.K., Jaiswal N., Bruder S.P., Mbalaviele G., Marshak D.R., Pittenger M.F. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol Chem. 2000, 275:9645-9652.
88. Lazarus H.M., Haynesworth S.E., Gerson S.L., Rosenthal N., Caplan A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells) (MPCs): implications for therapeutic use. Bone Marrow Trans. 1995, 16:557-564.
89. Koç O.N. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultured-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 2000, 18:307-316.
90. Osdoby P., Martini M.C., Caplan A.I. Isolated osteoclasts and their presumed progenitor cells, the monocyte, in culture. J. Exp. Biol. 1982, 224:331-344.
91. Collin-Osdoby P., Osdoby P. The role of nitric oxide in regulating bone remodeling. Biological Mechanisms of Tooth Movement and Craniofacial Adaptation 1996, 69-82. Harvard Society for the Advancement of Orthodontics, Kyoto, Japan. Z. Davidovitch (Ed.).
92. Caplan A.I. Embryonic development and the principles of tissue engineering. Novartis Foundation: Tissue Engineering of Cartilage and Bone 2003, John Wiley & Sons, Boston.
93. Caplan A.I. Tissue engineering designs for the future: new logics, old molecules. Tiss. Eng. 2000, 6:1-8.
94. Bruder S.P., Fink D.J., Caplan A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration. J. Cell Biochem. 1994, 56:283-294.
95. Bruder S.P., Caplan A.I. Bone Regeneration through cellular engineering. Principles in Tissue Engineering 2000, 683-696. Springer, London. 2nd ed. R. Lanza (Ed.).
96. Ohgushi H., Caplan A.I. Stem cell technology and bioceramics: from cell to gene engineering. J. Biomed. Mater Res. 1999, 48:913-927.
97. Bruder S.P., Kraus K.H., Goldberg V.M., Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone Joint Surg. Am. 1998, 80-A:985-996.
98. Wakitani S. Repair of rabbit articular cartilage surfaces with allograft chondrocytes embedded in collagen gel. J. Bone Joint Surg. Br. 1989, 71:74-80.
99. Caplan A.I., Elyaderani M., Mochizuki Y., Wakitani S., Goldberg V.M. The principles of cartilage repair/regeneration. Clin. Orth. Rel. Res. 1997, 342:254-269.
100. Solchaga L.A., Dennis J.E., Goldberg V.M., Caplan A.I. Hyaluronic acid-based polymers as cell carriers for tissue engineered repair of bone and cartilage. J. Orthop. Res. 1999, 17:205-213.
101. Solchaga L.A., Yoo J.U., Lundberg M., Dennis J.E., Huibregtse B.A., Goldberg V.M., Caplan A.I. Hyaluronic acid-based polymers in the treatment of osteochondral defects. J. Orthop Res. 2000, 18:773-780.
102. Solchaga L.A., Goldberg V.M., Caplan A.I. Hyaluronic acid-based biomaterials in tissue engineered cartilage repair. New Frontiers in Medical Sciences: Redefining Hyaluronan 2000, 233-246. Elsevier Science, NY. G. Abatangelo (Ed.).
103. Solchaga L.A., Goldberg V.M., Caplan A.I. Cartilage regeneration using principles of tissue engineering. Clin. Orthop. Suppl. 2001, 391:S161-S170.
104. Pavesio A., Abatangelo G., Borrione A., Brocchetta D., Hollander A.P., Kon E., Torasso F., Zanasi S., Marcacci M. Hyaluronan-based scaffolds (Hyalograft C) in the treatment of knee cartilage defects: Preliminary clinical findings. Novartis Foundation Symposium 249 2003, 203-217. Wiley, Amsterdam.
105. Kujawa M.J., Caplan A.I. Hyaluronic acid bonded to cell culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cell cultures. Dev. Biol. 1986, 114:504-518.
106. Kujawa M.J., Carrino D.A., Caplan A.I. Substrate-bonded hyaluronic acid exhibits a size- dependent stimulation of chondrogenic differentiation of stage24 limb mesenchymal cells in culture. Dev. Biol. 1986, 114:519-528.
107. Koc O.N., Peters C., Aubourg P., Raghavan S., Dyhouse S., Degasperi R., Kolodny E.H., Yoseph Y.B., Gerson S.L., Lazarus H.M., Caplan A.I. bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment afterallogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp. Hemtaol. 1999, 27:1675-1681.
108. Saito T., Dennis J.E., Lennon D.P., Young R.G., Caplan A.I. Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo. Tiss. Eng. 1996, 1:327-344.
109. Shake J.G., Gruber P.J., Baumgartner W.A., Senechal G., Meyers J., Redmond J.M., Pittenger M.F., Martin F.J. In vivo mesenchymal stem cell grafting in a swine myocardial infarct model: molecular and physiologic consequences. Ann. Thorac. Surg. 2002, 73:1919-1926.
110. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
111. Awad H., Butler D.L., Malaviag P., Boivin G.P., Smith F.N., Huibregste B., Caplan A.I. Autologous mesenchymal stem cell-mediated repair of tendon. Tiss. Eng. 1999, 5(3):267-277.
112. Caplan A.I. Osteogenesis imperfecta, rehabilitation medicine, and fundamental research. Conn. Tiss. Res. 1995, 31:S9-S14.
113. Horwitz E., Prockop D., Fitzpatrick L., Koo W., Gordon P., Neel M., Sussman M., Orchard P., Marx J., Pyeritz R., Brenner M. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
114. Horwitz E.M., Gordon P.L., Koo W.K.K., Arx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cellsengraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8932-8937.
115. Allay J.A., Dennis J.E., Haynesworth S.E., Majumdar M., Wade Clapp D., Caplan A.I., Gerson S.L. LacZ and IL-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther. 1997, 8:1417-1427.
116. Shimada T., Kitamura H., Nakamura M. Three-dimensional architecture of pericytes with special reference to their topographical relationship to microvascular beds. Arch. Histol. Cytol. 1992, 55:77-85. (Suppl.).
117. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
118. Peng H., Wright V. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein- 4. J. Clin. Invest. 2002, 110:751-759.
119. Thomas, T.N., and Haynesworth, S.E. (In preparation). Human mesenchymal stem cells and vascular endothelial cells reciprocally induce growth and migration. Biology, Case Western Reserve University.
120. Eglitis M.A., Mezey E. Hematopoietic cells differentiate into both microglia and microglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4080-4085.
121. Braxelton T.R., Rossi F.M.V., Keshet G.I., Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000, 290:1775-1779.
122. Black I.B., Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol. Dis. 2001, 27:632-636.
123. Mezey E., Chandross K.J., Harta G., Maki R.A., McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000, 290:1779-1782.
124. Dezawa M., Takahashi I., Esaki M., Takano M., Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur. J. Neuro. 2001, 14:1771-1776.